Company Sponsored Sessions

* Subject to Change

Wednesday October 3rd,2018

Medcape

Hall C4.4

13:00-14:30

Thursday, 4 October, 2018

Cepheid

Hall C4.4

7:45 – 9:15

Seegene

Hall C4.9
7:45 – 9:15


bd.png

The Utility and Simplicity of Extended Genotyping: From Theory to Practice
Hall C4.4
13.30-14.30
Lunch will be provided


Introduction                                              

Jeff Andrews, MD, FRCSC, Worldwide Medical Director for Women's Health Cancer, BD Diagnostics & BD Life Sciences

The Latest Advances in Cervical Cancer Screening and Management: Performance and Genotyping Results from the BD Onclarity HPV Assay US Clinical Trial
Thomas C.  Wright, Jr., MD, Professor Emeritus, Department of Pathology and Cell Biology, Columbia University & Past President of the American Society for Colposcopy and Cervical Pathology
  
The Impacts of Changing to Primary HPV Screening: for Women, Labs, Clinicians, Colposcopy, and Payers
Richard Massey, MB ChB, FRCPA , Histocytopathologist, Director of Pathology Associates, and Pathlab, New Zealand
 
Self-sampling and Extended Genotyping in a Primary HPV-based National Cervical Screening Program  
David Hawkes, PhD, Molecular Virologist and Executive Member of Victorian Cytology Service, Australia 


hologic.JPG

Meeting global challenges in cervical cancer screening through insight and proven clinical performance.

Hall C4.9
18:00 – 19:30 


Friday, October 5th, 2018

Roche

Hall B1

13:00-14:30


Keep Me Updated